BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9143406)

  • 1. Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlations with prognosis.
    Nakanishi H; Ohsawa M; Naka N; Uchida A; Ochi T; Aozasa K
    Oncology; 1997; 54(3):238-44. PubMed ID: 9143406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
    Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of argyrophilic nucleolar organizer staining for predicting prognosis of patients with recurrent soft tissue sarcoma.
    Kuratsu S; Ohsawa M; Naka N; Myoui A; Tomita Y; Uchida A; Ono K; Aozasa K
    Oncology; 1994; 51(3):244-50. PubMed ID: 8196907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of apoptosis-related markers TP53, BCL-2, BAX and c-MYC in female genital tract sarcomas.
    Liu FS; Jan YJ; Lai CR; Twu NF; Lu CH; Hung MJ; Hsieh YT; Chiou LC
    J Chin Med Assoc; 2008 Dec; 71(12):628-34. PubMed ID: 19114327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins.
    Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M
    Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis and expression of its regulatory proteins in soft tissue sarcomas.
    Dan'ura T; Kawai A; Morimoto Y; Naito N; Yoshida A; Inoue H
    Cancer Lett; 2002 Apr; 178(2):167-74. PubMed ID: 11867201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies.
    Nagler RM; Kerner H; Ben-Eliezer S; Minkov I; Ben-Itzhak O
    Oncology; 2003; 64(4):389-98. PubMed ID: 12759537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids.
    Brodowicz T; Wiltschke C; Kandioler-Eckersberger D; Grunt TW; Rudas M; Schneider SM; Hejna M; Budinsky A; Zielinski CC
    Br J Cancer; 1999 Jul; 80(9):1350-8. PubMed ID: 10424735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity of p53, Mdm2, p21(WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with histologic grade.
    Sabah M; Cummins R; Leader M; Kay E
    Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):64-9. PubMed ID: 17536310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of argyrophilic nucleolar organizer staining in soft-tissue sarcomas.
    Kuratsu S; Aozasa K; Myoui A; Tsujimoto M; Ueda T; Uchida A; Hamada H; Ono K; Matsumoto K
    Int J Cancer; 1991 May; 48(2):211-4. PubMed ID: 1708364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA ploidy pattern and cell cycle stage of tumor cells in soft-tissue sarcomas: clinical implications.
    Kuratsu S; Tomita Y; Myoui A; Uchida A; Ono K; Aozasa K
    Oncology; 1995; 52(5):363-70. PubMed ID: 7637952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of bcl-2, c-myc, survivin and tumor grade in synovial sarcoma.
    Demır D; Yaman B; Anacak Y; Keçecı B; Kandıloğlu G; Akalin T
    Turk Patoloji Derg; 2014; 30(1):55-65. PubMed ID: 24448706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Apoptosis-related Markers in Patients With Soft-Tissue Sarcomas of Extremities.
    Mühlbeier DF; Saddi VA; de Paula ÉC; Cunha IW; Fregnani JH; Barbosa MA; Manoel WJ
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):268-74. PubMed ID: 25906122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor size as a prognostic indicator of histologic grade of soft tissue sarcoma.
    Nakanishi H; Tomita Y; Ohsawa M; Naka N; Araki N; Ochi T; Aozasa K
    J Surg Oncol; 1997 Jul; 65(3):183-7. PubMed ID: 9236927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
    Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
    Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma.
    Sun B; Sun Y; Wang J; Zhao X; Wang X; Hao X
    Eur J Cancer Prev; 2006 Jun; 15(3):258-65. PubMed ID: 16679870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic grading in soft-tissue sarcomas. An analysis of 194 cases including AgNOR count and mast-cell count.
    Tomita Y; Aozasa K; Myoui A; Kuratsu S; Uchida A; Ono K; Matsumoto K
    Int J Cancer; 1993 May; 54(2):194-9. PubMed ID: 8486423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma.
    Pulkkinen JO; Klemi P; Martikainen P; Grénman R
    Anticancer Res; 1999; 19(1B):703-7. PubMed ID: 10216480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.